1
Aug 21, 2024
Breast cancer is a common female cancer occurring globally, and it is the most common cancer among Japanese women. Interestingly, it’s more likely to affect middle-aged women in Japan than older women, which is different from most other cancers①. There’s been a worldwide rise in breast cancer cases, especially noticeable in Japan too. This increase […]
2
Feb 16, 2024
Uchiken; 3H`s owned Home Nursing station achieves accreditation as Certified Home Nursing Service Provider, Enabling Enhanced Access to Clinical Trials for Patients 3H Medi solution Co., Ltd. Tokyo, Toshima-ward; represented by CEO Hirotaka Takizawa proudly announces its recent accreditation as a designated home nursing service provider. This accreditation, obtained on November 1, 2023, applies to […]
3
Sep 11, 2023
When conducting clinical trials, it is important to have a well-constructed recruitment pathway. Clinical trials which fail to meet the enrolment target could have substantial delays as well as have small sample sizes which could decrease the study power and lead to early termination. As many as 85% of clinical trials fail to meet recruitment […]
4
Sep 5, 2022
Recruitment remains a key challenge in clinical trial conduct. With the clinical trial protocols becoming more complex with stringent inclusion and exclusion criteria, it makes it more difficult to enrol and retain participants in clinical trials through traditional recruitment strategies. Decentralise clinical trials on the other hand have redefined successful recruitment, facilitating better subject engagement […]
5
Jan 24, 2022
Japan is rapidly moving into a society with a standardised digitalisation approach with modernised public services. This helps Japan to reinforce international competitiveness and also improves the convenience for Japanese citizens. This government led initiative towards digital transformation has helped in achieving a single administrative framework across Japan through the latest ‘Digital Agency’ initiative. Japan’s […]
6
Aug 7, 2019
3H Medi Solution (former CROee Inc), Japan, through a comprehensive interaction with associate organizations, such as University Hospital Clinical and Translational Research Center, has had a chance to delve into the existing challenges and future goals of the organization. One of the most important deliberations, pharmaceuticals and researchers, alike need to understand is the process […]
7
Jul 3, 2019
3H Medi Solution (formerly CROee INC), Japan, in furtherance with its organizational goals, recently had table talks with its prospective associate, Keio University Hospital, represented by Dr. Kenzo Soejima (MD Ph.D.), Director of Clinical and Translational Research Center at the University, wherein Dr. Soejima spoke about the ongoing activities and forward trends in Clinical Trials, […]
8
May 11, 2019
At present several clinical trials are conducted for the treatment of certain Lysosomal Storage Diseases (LSD) but faced with multiple challenges.one such challenge is that the results of ERT are not promising. Enzyme Replacement Therapy (ERT) is primarily used in LSD treatments, however the progress has not been satisfactory in some of the LSDs like […]
9
Apr 22, 2019
Earlier in this month of April, CROèe’s Oncology Team recently organized a felicitation seminar in Kyoto in honor of the Year 2018 Noble Laureate, Professor Honjo Tasuku, wherein the Noble Laureate received accolades for his outstanding work in the oncology field. Additionally, he was also thanked for saving and altering the lives of numerous cancer […]
10
Oct 3, 2018
Japan is considered to be one such country that differs greatly linguistically and culturally from Western countries. Another reason why major global pharmaceutical companies want to have Japan participate in global clinical trials is sales that can be made in Japan in the pharmaceutical market. The global pharmaceutical market is said to be worth approximately […]